Myriad Genetics (MYGN) Worth Watching: Stock Rises 11.5%

Myriad Genetics Inc. (MYGN) was a big mover last session with its shares rising over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading way above the past one month’s volatile price range of $32.75 to $38.17.

This molecular diagnostic company has been witness to 13 positive estimate revisions in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This indicates strong trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.

Myriad Genetics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Investors interested in the biomedical industry may also consider stocks like Alexion Pharmaceuticals, Inc. (ALXN), Gilead Sciences Inc. (GILD) and Actelion Ltd. (ALIOF). All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

MYRIAD GENETICS INC (MYGN): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research